Ausgabe 6/2010
Inhalt (10 Artikel)
The Addition of Rituximab to Fludarabine and Cyclophosphamide Improves Progression-free Survival in Patients with Previously Treated Chronic Lymphocytic Leukemia
Amit Mahipal, Mark Weiss
Targeted Signal Transduction Therapies in Myeloid Malignancies
Emma Scott, Elizabeth Hexner, Alexander Perl, Martin Carroll
Post-Transplantation Lymphoproliferative Disorders: Diagnosis, Prognosis, and Current Approaches to Therapy
Andrew M. Evens, Rupali Roy, Danielle Sterrenberg, Michelle Z. Moll, Amy Chadburn, Leo I. Gordon
Maintenance and Consolidation Strategies in Non-Hodgkin’s Lymphoma: A Review of the Data
Fredrick B. Hagemeister
Can Anthracycline Therapy for Pediatric Malignancies Be Less Cardiotoxic?
Joy M. Fulbright, Winston Huh, Pete Anderson, Joya Chandra